Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.

Hoste, LeviSoriano-Arandes, AntoniBuddingh, Emilie PaulineWhittaker, ElizabethBelot, AlexandreUlloa-Gutierrez, RolandoOlbrich, PeterHaerynck, Filomeen2023-05-032023-05-032022-09Hoste L; MIS-C researchers; Soriano-Arandes A, Buddingh EP, Whittaker E, Belot A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey. J Pediatr. 2022 Sep;248:114-118.http://hdl.handle.net/10668/22331The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.enAtribución-NoComercial-SinDerivadas 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/COVID-19MIS-CSARS-CoV-2adverse eventsvaccinationCOVID-19ChildHumansSARS-CoV-2Surveys and QuestionnairesSystemic Inflammatory Response SyndromeVaccinationSevere Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.report35598642open accessSíndrome de respuesta inflamatoria sistémicaSARS-CoV-2PandemiasSíndrome de Guillain-BarréVacuna BNT162Insuficiencia respiratoriaEnfermedad aguda10.1016/j.jpeds.2022.05.0281097-6833PMC9119291https://digital.csic.es/bitstream/10261/279790/1/Severe%20Acute%20Respiratory%20Syndrome%20Coronavirus%202%20Vaccination%20in%20Children.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119291/pdf